#1 |
34 |
30 |
postencephalitis/ negative MRI |
bitemp. |
NA |
Phase
II- FO |
- |
12-14 |
lacosamide 400, lamotrigine 400, oxcarbamazepine
600 |
#2 |
12 |
5 |
unknown |
bitemp. |
right |
Phase II- FO, Strip |
- |
12 |
carbamazepine CR 800, lamotrigine 300, clonazepam 0.5, clobasam 20,
quetiapine 50 |
#3 |
15 |
23 |
left HS |
bitemp. |
left |
Phase II- FO |
- |
4-5 |
carbamazepine CR 700, clobazam 20, zonisamide 200 |
#4 |
1 |
22 |
susp. Right cingular FCD |
bifront. |
left |
Phase I |
- |
1 |
clobasam 30 mg, lacosamide 400 mg, lamotrigine 200
mg |
#5 |
2 |
38 |
unknown |
multifocal fronto-temporal |
right |
Phase II-
Strip |
- |
2-4 |
zonisamide 300, lamotrigine 250 |
#6 |
11 |
32 |
bilateral HS |
bitemp. |
left |
Phase-I |
- |
1-2 |
lamotrigine 300 mg, lacosamide 300 mg, cenobamate 400 mg |
#7 |
18 |
18 |
bilat. parietal polymicrogyria, bilat. HS |
bitemp. |
right |
Phase II- FO |
VNS |
14-20 |
levetiracetam 3000, carbamazepine
1500, zonisamide 400 |
#8 |
12 |
13 |
bilateral HS |
bitemp. |
NA |
Phase II- FO |
VNS |
30 |
levetiracetam 3000 mg, lamotrigine 400 mg |
#9 |
23 |
18 |
uncertain HS with left dominance |
bitemp. |
left |
Phase II- FO |
- |
2-3 |
lacosamide 300, levetiracetam
1500 |
#10 |
12 |
34 |
assumed HS |
bitemp. |
left |
Phase II- FO |
right
temporal resection |
2-4 |
clobasam 20, oxcarbamazepine 600, lacosamide
400, topiramate 200 |
#11 |
27 |
12 |
left HS, postencephalitis |
multifocal fronto-temporal |
left |
Phase I. |
- |
4 |
lamotrigine 400 mg, brivaracetam 100
mg |
#12 |
20 |
19 |
bilat. subependymal heterotopia & non-regular
hippocampal anatomy, left closed lip schizencephaly |
bitemp. |
right |
Phase I |
- |
6-7 |
carbamazepine 1500, topiramate 100 |
#13 |
17 |
25 |
left temporal dysgenesis, peritrigonal heterotopy |
left fronto-temporal |
left |
Phase I |
left temporal resectio 2x, left
peritrigonal heterotopy resectio |
4-5 |
perampanel 10 mg, lacosamide
500 mg, gabapentin 1200 mg, alprazolam 1 mg |
#14 |
19 |
7 |
bilat. PVNH |
bitemp. |
right |
Phase I |
- |
2 |
oxcarbamazepine 1800, levetiracetam 2000, topiramate 300, sulthiam
300 |
#15 |
19 |
16 |
postencephalitis/ negative MRI |
left fronto-temporal |
left |
Phase II- Strip + Grid |
left temporal resection, VNS |
6-10 |
clonazepam 2, lamotrigine 425, phenobarbital 100, risperidone
2.5 |
1bitemp – bitemporal; FO – foramen ovale electrodes;
CR – controlled release; HS – hippocampal sclerosis; PVNH –
periventricular nodular heterotopia; VNS – vagus nerve stimulation; DBS
– deep brain stimulation; Phase I – video-EEG monitoring with scalp
electrodes; Phase II –video-EEG with invasive electrodes |
1bitemp – bitemporal; FO – foramen ovale electrodes;
CR – controlled release; HS – hippocampal sclerosis; PVNH –
periventricular nodular heterotopia; VNS – vagus nerve stimulation; DBS
– deep brain stimulation; Phase I – video-EEG monitoring with scalp
electrodes; Phase II –video-EEG with invasive electrodes |
1bitemp – bitemporal; FO – foramen ovale electrodes;
CR – controlled release; HS – hippocampal sclerosis; PVNH –
periventricular nodular heterotopia; VNS – vagus nerve stimulation; DBS
– deep brain stimulation; Phase I – video-EEG monitoring with scalp
electrodes; Phase II –video-EEG with invasive electrodes |
1bitemp – bitemporal; FO – foramen ovale electrodes;
CR – controlled release; HS – hippocampal sclerosis; PVNH –
periventricular nodular heterotopia; VNS – vagus nerve stimulation; DBS
– deep brain stimulation; Phase I – video-EEG monitoring with scalp
electrodes; Phase II –video-EEG with invasive electrodes |
1bitemp – bitemporal; FO – foramen ovale electrodes;
CR – controlled release; HS – hippocampal sclerosis; PVNH –
periventricular nodular heterotopia; VNS – vagus nerve stimulation; DBS
– deep brain stimulation; Phase I – video-EEG monitoring with scalp
electrodes; Phase II –video-EEG with invasive electrodes |
1bitemp – bitemporal; FO – foramen ovale electrodes;
CR – controlled release; HS – hippocampal sclerosis; PVNH –
periventricular nodular heterotopia; VNS – vagus nerve stimulation; DBS
– deep brain stimulation; Phase I – video-EEG monitoring with scalp
electrodes; Phase II –video-EEG with invasive electrodes |
1bitemp – bitemporal; FO – foramen ovale electrodes;
CR – controlled release; HS – hippocampal sclerosis; PVNH –
periventricular nodular heterotopia; VNS – vagus nerve stimulation; DBS
– deep brain stimulation; Phase I – video-EEG monitoring with scalp
electrodes; Phase II –video-EEG with invasive electrodes |
1bitemp – bitemporal; FO – foramen ovale electrodes;
CR – controlled release; HS – hippocampal sclerosis; PVNH –
periventricular nodular heterotopia; VNS – vagus nerve stimulation; DBS
– deep brain stimulation; Phase I – video-EEG monitoring with scalp
electrodes; Phase II –video-EEG with invasive electrodes |
1bitemp – bitemporal; FO – foramen ovale electrodes;
CR – controlled release; HS – hippocampal sclerosis; PVNH –
periventricular nodular heterotopia; VNS – vagus nerve stimulation; DBS
– deep brain stimulation; Phase I – video-EEG monitoring with scalp
electrodes; Phase II –video-EEG with invasive electrodes |
1bitemp – bitemporal; FO – foramen ovale electrodes;
CR – controlled release; HS – hippocampal sclerosis; PVNH –
periventricular nodular heterotopia; VNS – vagus nerve stimulation; DBS
– deep brain stimulation; Phase I – video-EEG monitoring with scalp
electrodes; Phase II –video-EEG with invasive electrodes |